The Food Allergy Diagnostics & Therapeutics Market size was estimated at USD 5.36 billion in 2022 and expected to reach USD 5.86 billion in 2023, at a CAGR 10.23% to reach USD 11.69 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Food Allergy Diagnostics & Therapeutics Market.

  • Based on Product Type, market is studied across Diagnostic Tests Type and Therapeutic Treatment Type. The Diagnostic Tests Type is further studied across In Vitro and In Vivo/Skin. The In Vivo/Skin is further studied across Patch Test and Skin Prick Test. The Therapeutic Treatment Type is further studied across Antihistamines and Epinephrine Auto-Injector. The Diagnostic Tests Type commanded largest market share of 66.79% in 2022, followed by Therapeutic Treatment Type.

  • Based on Technology, market is studied across Enzyme-Linked Immunosorbent Assay and Polymerase Chain Reaction. The Enzyme-Linked Immunosorbent Assay commanded largest market share of 35.43% in 2022, followed by Polymerase Chain Reaction.

  • Based on Source, market is studied across Eggs, Fish, Milk, Peanuts, Shellfish, Soy, Tree Nuts, and Wheat. The Shellfish commanded largest market share of 23.63% in 2022, followed by Milk.

  • Based on Component, market is studied across Consumables, Instruments, and Services. The Instruments commanded largest market share of 47.23% in 2022, followed by Services.

  • Based on End-User, market is studied across Academic Research Institutes, Diagnostics Laboratories, and Hospitals & Clinics. The Hospitals & Clinics commanded largest market share of 39.97% in 2022, followed by Diagnostics Laboratories.

  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.64% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Food Allergy Diagnostics & Therapeutics Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Food Allergy Diagnostics & Therapeutics Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Food Allergy Diagnostics & Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 7 Drops Diagnostics, Inc., ACON Laboratories, Inc., AESKU.GROUP GmbH, ALK-Abell? A/S, Allergy Therapeutics PLC, Alpha Laboratories, Apexhealth by Acecgt Diagnostic Limited, Apollo Diagnostics, Aster Clinical Lab LLP, Astra Biotech GmbH, bioM?rieux SA, Cerascreen GmbH, Eurofins Scientific (Ireland) Limited, EUROIMMUN Medizinische Labordiagnostika AG, HollisterStier Allergy by Jubilant Pharma Holdings Inc., HYCOR Biomedical, Indoor Biotechnologies, Inc., Laboratory Corporation of America Holdings., Lincoln Diagnostics, Inc., Medeca Pharma AB, Microbac Laboratories, Inc., Minaris Medical America, Inc., Neogen Corporatio, Nestl? Health Science, Omega Diagnostics Group PLC, Prota Therapeutics Pty. Ltd., Quest Consumer Inc., R-Biopharm AG, Romer Labs Division Holding GmbH, ROXALL Medizin GmbH, Siemens AG, STALLERGENES GREER International AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

The report offers valuable insights on the following aspects:

  1. Market Penetration: It provides comprehensive information about key players’ market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast for the Food Allergy Diagnostics & Therapeutics Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Food Allergy Diagnostics & Therapeutics Market?
  3. What is the competitive strategic window for identifying opportunities in the Food Allergy Diagnostics & Therapeutics Market?
  4. What are the latest technology trends and regulatory frameworks in the Food Allergy Diagnostics & Therapeutics Market?
  5. What is the market share of the leading vendors in the Food Allergy Diagnostics & Therapeutics Market?
  6. Which modes and strategic moves are suitable for entering the Food Allergy Diagnostics & Therapeutics Market?